BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 17409326)

  • 21. Acute hepatitis C and HIV coinfection.
    Dionne-Odom J; Osborn MK; Radziewicz H; Grakoui A; Workowski K
    Lancet Infect Dis; 2009 Dec; 9(12):775-83. PubMed ID: 19926037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug therapy of hepatitis B and C].
    Färkkilä M
    Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection.
    Bartlett JG
    Hopkins HIV Rep; 2005 May; 17(3):15. PubMed ID: 16419314
    [No Abstract]   [Full Text] [Related]  

  • 24. [Protocol for the antiviral therapy of hepatitis C].
    Judit G; Gábor H; Béla H; Mihály M; Alajos P; Ferenc S; István T; László T; ;
    Orv Hetil; 2010 Jan; 151(2):66-72. PubMed ID: 20061235
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis? What is it?].
    Hernández ML
    Sidahora; 2002; (4):11-3. PubMed ID: 12703473
    [No Abstract]   [Full Text] [Related]  

  • 26. Cure of acute hepatitis C in HIV co-infection?
    Ristig MB; Tebas P; Gandy I; Qaqish R; Aberg JA
    J Clin Gastroenterol; 2004 Mar; 38(3):303. PubMed ID: 15128087
    [No Abstract]   [Full Text] [Related]  

  • 27. Sustained viral response after only 6 weeks of peginterferon and ribavirin treatment for acute hepatitis C in a HIV-1-infected patient.
    van den Berk GE; Arends JE
    AIDS; 2011 Jul; 25(12):1553-4. PubMed ID: 21747237
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic challenges of hepatitis C.
    Konerman MA; Lok AS
    JAMA; 2014 Jun; 311(24):2536-7. PubMed ID: 25058088
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute hepatitis C virus infection--clinical manifestations, diagnosis and treatment].
    Peters L; Lindhardt BØ
    Ugeskr Laeger; 2006 Oct; 168(42):3601-4. PubMed ID: 17069720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primer treatment of acute and chronic hepatitis C].
    Daruich J; Fainboim H; Frider B
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S52-6; discussion S74-82. PubMed ID: 16862862
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
    Boyle BA
    AIDS Read; 2001 Aug; 11(8):387-90, 397. PubMed ID: 11570261
    [No Abstract]   [Full Text] [Related]  

  • 32. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV/HCV double infection: combination is a clear therapy option].
    Reich B
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
    [No Abstract]   [Full Text] [Related]  

  • 34. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.
    Sterling RK
    Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556
    [No Abstract]   [Full Text] [Related]  

  • 35. PegIFN/ribavirin during acute HCV coinfection.
    Bernard EJ
    IAPAC Mon; 2004 Jul; 10(7):260-1. PubMed ID: 15624247
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interferon therapy for chronic hepatitis B].
    Tang WL; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):726-9. PubMed ID: 19874685
    [No Abstract]   [Full Text] [Related]  

  • 37. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
    Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
    Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
    D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
    AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hepatitis C virus infection in patients with concurrent human immunodeficiency virus infection].
    Peters L; Lindhardt BØ
    Ugeskr Laeger; 2006 Oct; 168(42):3604-8. PubMed ID: 17069721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.